Jazz Pharmaceuticals Receivables 2010-2024 | JAZZ

Jazz Pharmaceuticals receivables for the quarter ending September 30, 2024 were $0.724B, a 15.26% increase year-over-year.

  • Jazz Pharmaceuticals receivables for 2023 were $0.706B, a 8.33% increase from 2022.
  • Jazz Pharmaceuticals receivables for 2022 were $0.651B, a 15.64% increase from 2021.
  • Jazz Pharmaceuticals receivables for 2021 were $0.563B, a 42.09% increase from 2020.

Jazz Pharmaceuticals Receivables 2010-2024 | JAZZ

  • Jazz Pharmaceuticals receivables for 2023 were $0.706B, a 8.33% increase from 2022.
  • Jazz Pharmaceuticals receivables for 2022 were $0.651B, a 15.64% increase from 2021.
  • Jazz Pharmaceuticals receivables for 2021 were $0.563B, a 42.09% increase from 2020.